Coverage by BioWorld News as tracked by Newsylist.
The FDA has granted approval to Otsuka for Simtriyo, marking the introduction of the first triple reuptake inhibitor for the treatment of ADHD.
7 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Capricor Therapeutics shares have plunged after FDA staff raised concerns regarding the efficacy and data of its Duchenne heart disease therapy.
5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.
7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
A growing divide in the brain-computer interface market pits surgical implants against non-invasive wearable technology.
Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.